AXS
AXIS Capital Holdings Limited
AXS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC
Bank of America Corporation
BAC has a slight edge over AXS overall, supported by stronger modeled upside and stronger fundamentals.
AXS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
AXS's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like AXS.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AXS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $106 | -2.2% |
| Current | 8.3x | $108 | — |
| Forward | 8.4x | $108 | — |
| Fair | 11x | $141 | +31% |
| Expensive | 17x | $219 | +102% |
Historical ranges are pointers, not guarantees.
AXS has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
AXS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect AXS's revenue to grow, with its earnings and profitability holding steady.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over AXS on the outlook, with more favorable valuation and earnings expectations.
AXS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.88 | -1.3% |
| Q3 2026 | $13.05 | +7.9% |
| Q2 2026 | $14.04 | +35% |
| Q1 2026 | $13.38 | +33% |
| Q4 2025 | $12.35 | 0% |
| Q3 2025 | $12.10 | +68% |
| Q2 2025 | $10.40 | +43% |
| Q1 2025 | $10.08 | +54% |
| Q4 2024 | $12.35 | +207% |
AXS earned $13.05 per share over the past year, up 7.9% from the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
AXS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.8B | +6.9% |
| Q2 2026 | $1.8B | +7.4% |
| Q1 2026 | $1.6B | +8% |
| Q4 2025 | $1.7B | +18% |
| Q3 2025 | $1.7B | +3.9% |
| Q2 2025 | $1.6B | +13% |
| Q1 2025 | $1.5B | +6.8% |
| Q4 2024 | $1.5B | -0.6% |
AXS's revenue has grown year over year for seven quarters in a row: $1.8B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -7.8 points |
| Q2 2026 | 18% | +0.9 points |
| Q1 2026 | 19% | +3.2 points |
| Q4 2025 | 19% | +0.4 points |
| Q3 2025 | 22% | +7.9 points |
| Q2 2025 | 17% | -0.3 points |
| Q1 2025 | 16% | -3.5 points |
| Q4 2024 | 19% | +31 points |
AXS's operating margin was 14% last quarter, down 7.8 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over AXS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AXS on profitability, with a higher operating margin.
AXS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $877.5M | +30% |
| Q2 2026 | $631.5M | +$2.3B |
| Q1 2026 | $519.4M | +68% |
| Q4 2025 | $630.4M | +77% |
| Q3 2025 | $673.8M | +15% |
| Q2 2025 | -$1.7B | -419% |
| Q1 2025 | $309.1M | -20% |
| Q4 2024 | $355.5M | +16% |
AXS has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AXS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -830K shares |
| 1 year | -6.7% | -5.2M shares |
| 3 years | -15% | -12.7M shares |
| 5 years | -14% | -12M shares |
| Available history | -13% | -11.1M shares |
AXS has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $109.5M |
| Q2 2026 | $89.3M |
| Q1 2026 | $59.5M |
| Q4 2025 | $287.8M |
| Q3 2025 | $110M |
| Q2 2025 | $50M |
| Q1 2025 | $440M |
| Q4 2024 | $60.1M |
AXS spent $546M buying back its own shares over the past year, down 17% from the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AXS Net Leverage
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
AXS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.4 | Neutral |
| Stochastic | 68.1 | Neutral |
AXS's weekly RSI is 59 (neutral) and its Stochastic is 68 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AXS PE vs Financial Services Sector
| Metric | AXS | Sector median | Relative |
|---|---|---|---|
| PE | 8.3x | 13x | 36% below |
| PE % | 21 | 63 | 42 pts below |
AXS has the edge over BAC on valuation relative to its sector.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AXS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.9 | 7.3% above |
| 20 week MA | $103.6 | 4.5% above |
| 50 week MA | $102.6 | 5.5% above |
| 100 week MA | $99.3 | 9% above |
| 200 week MA | $81.5 | 33% above |
AXS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AXS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.6 | $50.4 | -16% |
| 2021 | $50.4 | $52.1 | +3.4% |
| 2022 | $52.1 | $54.8 | +5.3% |
| 2023 | $54.8 | $55.4 | +1% |
| 2024 | $55.4 | $89.3 | +61% |
| 2025 | $89.3 | $109.0 | +22% |
| 2026 YTD | $109.0 | $108.2 | -0.7% |
AXS has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.